Investor Presentaiton

2 INVESTOR 20 DAY 23 Scalable commercial growth enables continuous improvement through data, biobank, clinical insights and real- world evidence 1 High performance in detecting early- stage cancer Positive unit economics to scale shield™ Broad reimbursement & access Patient preference 3 GUARDANT™ 4 123

View entire presentation